Clinical Trial Update: Caffeine for Apnea of Prematurity-Sleep (CAP-S) Study [Phase 3]

View source ↗

Summary

This clinical trial update reports the completion of Phase 3 CAP-S study evaluating caffeine (caffeine citrate) for Apnea of Prematurity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Apnea of Prematurity

Drugs mentioned

• Caffeine citrate (caffeine citrate)

Snippet

Sponsor: McMaster University | Conditions: Apnea of Prematurity | Phase 3 | Status: COMPLETED